Array Biopharma (ARRY) Misses Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $8.00 +4.44%
Revenue Growth %: -11.6%
Financial Fact:
Weighted average shares outstanding - basic (in shares): 145.1M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -11.6%
Financial Fact:
Weighted average shares outstanding - basic (in shares): 145.1M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Array Biopharma (NASDAQ: ARRY) reported Q3 EPS of ($0.16), $0.04 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $43 million versus the consensus estimate of $30.35 million.
For earnings history and earnings-related data on Array Biopharma (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- JPMorgan Upgrades YDUQS Participacoes SA (YDUQ3:BZ) to Overweight
- Micron Technology (MU) PT Raised to $1,300 at Bernstein SocGen Group
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
